FDA Inspection 1277271 — Eurofins Biopharma Product Testing India Private Ltd.
The FDA completed an inspection of Eurofins Biopharma Product Testing India Private Ltd. on Jun 20, 2025 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 20, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)